Manufacture of pharmaceutical preparations
PHARMAVAX HOLDING AS
Revenue 2024
NOK 0
Operating profit
NOK −26,000
Equity
NOK 5.0m
Incorporated
2022
Share capital
NOK 40,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 0 | |
| Total operating costs | 26k | |
| Operating profit (EBIT) | −26k | |
| Net financial items | 57k | |
| Profit for the year | 24k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 5.1m | |
| of which current assets | 5.0m | |
| Equity | 5.0m | |
| Total liabilities | 7k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.